Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma

Status unconfirmed · Phase 3

Conditions studied: Lymphoma

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Vaccines may make the body build an immune response to kill cancer cells. It is not yet known which regimen of chemotherapy combined with vaccine therapy is more effective for non-Hodgkin's lymphoma. PURPOSE: Randomized phase III trial to determine the effectiveness of combination chemotherapy followed by vaccine therapy plus sargramostim in treating patients who have stage III or stage IV non-Hodgkin's lymphoma.

Key facts

Study ID

NCT00017290

Run by

Genitope Corporation

Starts

2000-11-01

Last updated by the study team

2013-12-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• SuperGen, Incorporated — Dublin, California, United States
• California Cancer Care, Inc. — Greenbrae, California, United States
• Jonsson Comprehensive Cancer Center, UCLA — Los Angeles, California, United States
• Stanford Cancer Center at Stanford University Medical Center — Stanford, California, United States
• Rocky Mountain Cancer Centers - Midtown — Denver, Colorado, United States
• Shands Cancer Center at the University of Florida Health Science Center — Gainesville, Florida, United States
• Mountain States Tumor Institute - Boise — Boise, Idaho, United States
• Rush Cancer Institute at Rush University Medical Center — Chicago, Illinois, United States
• Indiana University Cancer Center — Indianapolis, Indiana, United States
• Holden Comprehensive Cancer Center at University of Iowa — Iowa City, Iowa, United States
• Greenebaum Cancer Center at University of Maryland Medical Center — Baltimore, Maryland, United States
• Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland, United States
• Veterans Affairs Medical Center - Ann Arbor — Ann Arbor, Michigan, United States
• University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan, United States
• Washington University School of Medicine — St Louis, Missouri, United States
• UNMC Eppley Cancer Center at the University of Nebraska Medical Center — Omaha, Nebraska, United States
• Cancer Center at Hackensack University Medical Center — Hackensack, New Jersey, United States
• New York Weill Cornell Cancer Center at Cornell University — New York, New York, United States
• Arthur G. James Cancer Hospital - Ohio State University — Columbus, Ohio, United States
• Cancer Institute at Oregon Health and Science University — Portland, Oregon, United States
• Sarah Cannon Cancer Center at Centennial Medical Center — Nashville, Tennessee, United States
• Cross Cancer Institute — Edmonton, Alberta, Canada
• British Columbia Cancer Agency — Vancouver, British Columbia, Canada
• Toronto Sunnybrook Regional Cancer Centre — Toronto, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.